T. Greene John's most recent trade in CRISPR Therapeutics AG was a trade of 13,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CRISPR Therapeutics AG | John T. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | John T. Greene | Director | Purchase of securities on an exchange or from another person at price $ 44.85 per share. | 26 Feb 2025 | 7,000 | 7,000 (0%) | 0% | 44.8 | 313,948 | Common Shares |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.09 per share. | 01 Feb 2025 | 1,840 | 79,866 (0%) | 0% | 201.1 | 370,006 | Common Stock |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 14,630 | 81,706 (0%) | 0% | 0 | Common Stock | |
| Discover Financial Services | Greene John T. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 12,109 | 78,778 (0%) | 0% | 0 | Common Stock | |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 169.27 per share. | 19 Dec 2024 | 11,702 | 67,076 (0%) | 0% | 169.3 | 1,980,798 | Common Stock |
| CRISPR Therapeutics AG | John T. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Discover Financial Services | Greene T. John | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 29,324 | 57,427 (0%) | 0% | 0 | Common Stock | |
| Discover Financial Services | T. John Greene | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 9,051 | 66,478 (0%) | 0% | 0 | Common Stock | |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 21,801 | 40,393 (0%) | 0% | 0 | Common Stock | |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 21,801 | 40,393 (0%) | 0% | 0 | Common Stock | |
| Discover Financial Services | T. Greene John | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.56 per share. | 01 Feb 2024 | 12,290 | 28,103 (0%) | 0% | 106.6 | 1,309,622 | Common Stock |
| Discover Financial Services | John Greene T. | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.56 per share. | 01 Feb 2024 | 12,290 | 28,103 (0%) | 0% | 106.6 | 1,309,622 | Common Stock |
| Discover Financial Services | John Greene T. | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 106.51 per share. | 26 Jan 2024 | 35,191 | 18,592 (0%) | 0% | 106.5 | 3,748,193 | Common Stock |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 9,960 | 53,539 (0%) | 0% | 0 | Common Stock | |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 25,196 | 57,662 (0%) | 0% | 0 | Common Stock | |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.83 per share. | 01 Feb 2023 | 14,083 | 43,579 (0%) | 0% | 115.8 | 1,631,234 | Common Stock |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.22 per share. | 01 Aug 2022 | 1,752 | 32,275 (0%) | 0% | 102.2 | 179,089 | Common Stock |
| CRISPR Therapeutics AG | John T. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 7,339 | 33,952 (0%) | 0% | 0 | Common Stock | |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 127.95 per share. | 15 Feb 2022 | 4,443 | 26,613 (0%) | 0% | 127.9 | 568,464 | Common Stock |
| Discover Financial Services | John T. Greene | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.02 per share. | 01 Feb 2022 | 2,079 | 31,056 (0%) | 0% | 118.0 | 245,364 | Common Stock |
| Discover Financial Services | John T. Greene | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.32 per share. | 01 Aug 2021 | 1,752 | 33,135 (0%) | 0% | 124.3 | 217,809 | Common Stock |
| CRISPR Therapeutics AG | John T. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Discover Financial Services | John T. Greene | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 9,690 | 34,887 (0%) | 0% | 0 | Common Stock | |
| Discover Financial Services | John T. Greene | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.19 per share. | 01 Feb 2021 | 1,146 | 25,197 (0%) | 0% | 82.2 | 94,190 | Common Stock |
| Discover Financial Services | John Greene T. | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.43 per share. | 01 Aug 2020 | 1,159 | 26,343 (0%) | 0% | 49.4 | 57,289 | Common Stock |